Supplemental file for "The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor" (Small, B et al., JCEM 2019).
shannon whirledge (7410653)
core +1 more source
Risk-efficacy balance of ulipristal acetate compared to surgical alternatives. [PDF]
Middelkoop MA +4 more
europepmc +1 more source
Cyclodextrin and its derivatives as effective excipients for amorphous ulipristal acetate systems. [PDF]
Wang P, Wang Y, Suo Z, Zhai Y, Li H.
europepmc +1 more source
Aim To evaluate various adverse symptoms during short-term use of ulipristal acetate in women with uterine myomas (n = 90), adenomyosis (n = 3) or both (n = 7). Methods One hundred premenopausal women who received ulipristal acetate for 4-12 weeks during
Soo Jin Han +10 more
core +1 more source
Ulipristal Acetate Modifies miRNA Expression in Both Superficial and Basal Layers of the Human Endometrium. [PDF]
Kolanska K +9 more
europepmc +1 more source
Histological pattern of leiomyomas after ulipristal acetate treatment in women: A case-control study
Purpose of Investigation: Assessing cytological and extracellular matrix histological patterns of uterine leiomyomas, in women previously treated with ulipristal acetate (UPA).
Pedriali M. +5 more
core +1 more source
Updated approaches for management of uterine fibroids
Aymara Mas,1,2 Marta Tarazona,3 Joana Dasí Carrasco,3 Gloria Estaca,4,5 Ignacio Cristóbal,4,5 Javier Monleón3 1Reproductive Medicine Research Group, Institute of Health Research La Fe, University and Polytechnic Hospital La Fe ...
Mas A +5 more
doaj
Background The Emergency contraception pills (ECPs) are being used worldwide to prevent unwanted pregnancy, but the most important issue is still unanswered: whether they are effective when taken during or after ovulation, especially when taken near the ...
Ravi Yadav, Debasrita Banerjee
doaj +1 more source
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study. [PDF]
Brache V +15 more
europepmc +1 more source
Phase III long-term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids. [PDF]
Osuga Y +3 more
europepmc +1 more source

